The most widely accepted model explaining the progress of AD suggests that Aβ pathology may be an upstream event in AD and function as a trigger of downstream pathways, including tau-mediated toxicity, the misfolding of phosphorylated tau proteins, their accumulation in tangles, and the proliferation of tau proteins that leads to cortical neurodegeneration [16]. Here, MAPT is linked to Alzheimer disease.